CeriBell, Inc. is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining highly portable and rapidly deployable hardware with artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA-cleared (510(k)) for indicating suspected seizure activity and utilized in intensive care units and emergency rooms across the United States. Clarity, its machine learning algorithm, continuously interprets a patient’s EEG waveforms and displays actionable insights regarding seizure activity on the recorder. Its EEG portal is a cloud-based portal that enables real-time remote access to a patient’s EEG data.
公司代碼CBLL
公司名稱CeriBell Inc
上市日期Oct 11, 2024
CEOChao (Xingjuan)
員工數量281
證券類型Ordinary Share
年結日Oct 11
公司地址360 N. Pastoria Avenue
城市SUNNYVALE
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編94085
電話18004360826
網址https://ceribell.com/
公司代碼CBLL
上市日期Oct 11, 2024
CEOChao (Xingjuan)